Hamilton Morris & Ethan Nadelmann discuss Drug Policy

Drug policy reform and the societal impact of drug prohibition are explored through the lens of history and modern industry. The conversation contrasts the criminalization of cannabis and synthetics with medical advancements, while examining the influence of pharmaceutical companies on drug policy and the role of corporate funding in research. Societal issues surrounding the opioid epidemic, the ethics of medical marketing, and the complexities of drug-related mortality are analyzed. The dialogue critically evaluates the systemic challenges in drug control, highlighting the shift from criminal punishment toward public health initiatives as potential strategies for harm reduction and the ongoing evolution of legal landscapes.